FMP
Soliton, Inc.
SOLY
NASDAQ
Inactive Equity
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
22.58 USD
0 (0%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Christopher C. Capelli
sector
Healthcare
industry
Medical - Devices
website
https://www.soliton.comexchange
NASDAQ
Description
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
CIK
0001548187
ISIN
US8342511008
CUSIP
834251100
Address
5304 Ashbrook Dr
Phone
18326613453
Country
US
Employee
13
IPO Date
Feb 19, 2019
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
SOLY Financial Summary
CIK
0001548187
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
834251100
ISIN
US8342511008
Country
US
Price
22.58
Beta
0.18
Volume Avg.
182.84k
Market Cap
0
Shares
-
52-Week
22.56-22.59
DCF
24.86
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0
P/B
-
Website
https://www.soliton.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SOLY News
It looks like there's no news available.
